Testing different doses of a new medicine (fenebrutinib) and its effect on heart rhythm (QT interval) in healthy people

Autoimmune Disorder
Multiple Sclerosis (MS)
Neurodegenerative Disorder
Relapsing Multiple Sclerosis (RMS)

Results
Download

Study results

LPS GP42654 Final Results March 2024 English (PDF, 0.2 MB)

LPS GP42654 Final Results March 2024 USA Spanish (PDF, 0.2 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Testing different doses of a new medicine (fenebrutinib) and its effect on heart rhythm (QT interval) in healthy people

Study results

LPS GP42654 Final Results March 2024 English (PDF, 0.2 MB)

LPS GP42654 Final Results March 2024 USA Spanish (PDF, 0.2 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

Testing different doses of a new medicine (fenebrutinib) and its effect on heart rhythm (QT interval) in healthy people

For the latest version of this information please go to www.forpatients.roche.com